Best GLP-1 for Weight Loss: Clinical Factors & Personalization

Last reviewed: May 24, 2026

Last updated: May 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

The best GLP-1 medication for weight loss depends on individual physiology, tolerability, and clinical response—not a single universal answer. GLP-1 receptor agonists show efficacy ranges from 5–22% body weight reduction depending on the agent, dose, duration, and patient baseline.

PlexusDx recognizes that GLP-1 selection involves more than efficacy data: it requires matching mechanism of action, side effect profile, and genetic predispositions to individual circumstances. Understanding these clinical factors empowers informed conversations with providers about which option may align with your specific health profile.

Mechanism Differences: Semaglutide, Tirzepatide, and Retatrutide Explained

Semaglutide is a selective GLP-1 receptor agonist that increases satiety, slows gastric emptying, and improves glucose control. Clinical trials show average weight loss of 9–15% over 68 weeks at therapeutic doses, with well-established long-term safety data.

Tirzepatide is a dual GIP/GLP-1 receptor agonist, engaging both pathways to enhance weight loss and metabolic control. Studies demonstrate 19–22% body weight reduction over 72 weeks, suggesting greater efficacy than semaglutide alone for some patients, though side effect profiles differ.

Clinical Efficacy and Tolerability Comparison

Direct head-to-head comparisons inform which medication may suit your clinical profile. The table below summarizes key differences in weight loss outcomes, mechanism, and common adverse effects across three leading GLP-1 agents.

Medication	Average Weight Loss	Primary Mechanism	Common Side Effects	Typical Dosing
Semaglutide	9–15% body weight	GLP-1 agonist only	Nausea, constipation, fatigue	0.5–2.4 mg weekly
Tirzepatide	19–22% body weight	GLP-1 + GIP agonist	Nausea, vomiting, diarrhea	2.5–15 mg weekly
Retatrutide	22–25% body weight (Phase 3)	GLP-1 + GIP + GCG agonist	Nausea, GI effects (under study)	1–15 mg weekly
Cost Consideration	Compounded options available	Varies by formulation	Accessibility and insurance vary	Check provider pricing

Genetic Predispositions That May Inform Medication Response

Individual variation in GLP-1 receptor sensitivity and metabolic pathways is partly explained by genetic architecture. Variants in GLP1R, GIPR, and FTO genes influence baseline appetite regulation, insulin secretion, and response magnitude to GLP-1 therapy.

The Precision Peptide Genetic Test evaluates predispositions in these peptide pathways, helping providers contextualize why one medication may resonate better with your physiology than another. This insight should complement, not replace, clinical evaluation and provider judgment about medication selection.

Provider-Led Selection: Safety, Eligibility, and Personalized Dosing

Choosing the best GLP-1 medication requires medical assessment of contraindications, comorbidities, and prior treatment response. Patients with history of medullary thyroid cancer, personal or family history of thyroid disease, or pancreatitis risk require careful evaluation before initiation.

A qualified provider will assess your baseline BMI, metabolic state, kidney function, and tolerance for GI side effects to recommend starting dose and escalation schedule. Regular follow-up monitoring ensures efficacy, detects adverse effects early, and allows dose optimization over time.

How PlexusDx Supports a More Personalized Approach

PlexusDx offers compounded semaglutide and tirzepatide formulations from licensed 503A pharmacies, providing accessible alternatives to branded medications. Genetic testing through PlexusDx may help provide context about your peptide pathway predispositions, informing conversations with your provider about which mechanism and dosing strategy aligns with your physiology.

The Precision Peptide Genetic Test reveals predispositions in GLP1R, GIPR, FTO, and MC4R variants—not exact medication response. These patterns suggest which metabolic pathways may be relevant to your weight management physiology and can support a more informed provider discussion about starting agent and expected timeline.

Understanding your genetic context alongside clinical efficacy data and tolerability enables your provider to make a more personalized recommendation. PlexusDx compounded medications combined with genetic insights create a framework for precision-guided GLP-1 selection rather than generic one-size-fits-all approaches.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $279/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.